A detailed history of Ever Source Wealth Advisors, LLC transactions in Insmed Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 262 shares of INSM stock, worth $18,670. This represents 0.0% of its overall portfolio holdings.

Number of Shares
262
Previous 174 50.57%
Holding current value
$18,670
Previous $11,000 72.73%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$62.0 - $79.01 $5,456 - $6,952
88 Added 50.57%
262 $19,000
Q2 2024

Aug 13, 2024

BUY
$22.0 - $69.71 $1,716 - $5,437
78 Added 81.25%
174 $11,000
Q2 2023

Aug 04, 2023

BUY
$16.44 - $21.1 $1,167 - $1,498
71 Added 284.0%
96 $2,000
Q1 2023

May 11, 2023

BUY
$16.26 - $21.73 $406 - $543
25 New
25 $0
Q2 2022

Aug 01, 2022

SELL
$17.07 - $25.71 $3,089 - $4,653
-181 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$25.89 - $33.45 $4,686 - $6,054
181 New
181 $5,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.